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Obesity is an increasing problem worldwide and is associated with serious health risks.
Obesity not only reduces physical health, but can also negatively affect levels of perceived
stress, mood symptoms, sleep quality and quality of life (QoL), which may lead to further
weight gain. We have previously shown that a pre-conception lifestyle intervention reduced
weight and improved physical QoL in the short term. In the current study, we assessed the
effects of this intervention in women with obesity and infertility on perceived stress, mood
symptoms, sleep quality and QoL five years after randomization.
Methods and findings
We followed women who participated in the LIFEstyle study. This is a multi-center random-
ized controlled trial comparing a six-month lifestyle intervention to improve diet and increase
physical activity followed by infertility treatment, versus prompt infertility treatment. Partici-
pants were 577 women with infertility between 18 and 39 years of age with a body mass
index (BMI)� 29 kg/m2. For the current study we measured perceived stress, mood symp-
toms, sleep quality and QoL in 178 women five years after randomization. T-tests and linear
regression models were used to assess differences between the intervention and control
groups.
Five years after randomization, no differences were observed for perceived stress, mood
symptoms, sleep quality and QoL between the intervention (n = 84) and control groups (n =
94). There was selective participation: women who did not participate in the follow-up had
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lower baseline mental QoL, and benefitted more from the intervention in terms of improved
physical QoL during the original LIFEstyle intervention.
Conclusions
We found no evidence that a pre-conception lifestyle intervention improved female well-
being five years after randomization.
Introduction
Obesity is an increasing health problem across the world, with rates as high as 40% among
adults in the US [1]. In Europe the prevalence of overweight in 2014 has been estimated to be
almost 40%, and obesity 16% [2]. Obesity not only reduces physical health [3], but may also
have adverse consequences for mental health and quality of life (QoL). Obesity was associated
with lower self-reported QoL in adults, and this lower QoL was even more evident in those
with increased degrees of obesity [4]. Higher body weight in women was associated with
higher levels of psychological and perceived stress [5]. Furthermore, depressive and anxiety
disorders seem to be more prevalent in people with obesity, especially among women and
those with severe obesity [6]. A bidirectional pathway might explain the causal links between
obesity and depression, in which obesity leads to more depressive symptoms, and depressive
symptoms lead to physiological and psychosocial alterations associated with weight gain [7].
Obesity was also associated with short sleep duration and low sleep quality, which in turn was
associated with weight gain [8]. The higher prevalence of obstructive sleep apnea in adults
with obesity is one of the possible causes of impaired sleep quality [8]. Low sleep quality was
associated with lower QoL, more depressive symptoms and an increased cardiovascular dis-
ease risk [9–11]. These interrelations underline the importance of helping individuals not only
with their obesity but also their associated mental health concerns.
Lifestyle interventions form the first step in the treatment of overweight and obesity. Opti-
mal timing of an intervention can be important. In women, the pre-conception period pro-
vides a good opportunity to try to change lifestyle, since women are especially receptive to
lifestyle advice in this time span [12]. In the LIFEstyle study, women with obesity and infertility
were randomized between a lifestyle intervention group and a control group. During and
directly after the six-month intervention period women in the lifestyle intervention group
weighed less, presented less often with metabolic syndrome and reported better physical QoL
scores compared to the control group [13]. The intervention did not improve mental QoL in
the short-term.
Other lifestyle interventions aimed at weight loss have been shown to reduce the risks of
associated mood problems and impaired sleep quality [14, 15]. A systematic review and meta-
analysis showed that lifestyle interventions aiming at weight loss also reduced symptoms of
depression [14]. In addition, two behavioral weight loss interventions demonstrated better
sleep quality after a successful reduction in body weight [15]. However, these reductions were
observed during the intervention period, or immediately after the intervention. Long-term
effects of lifestyle interventions on weight reduction are disappointing [16], and research
regarding the effects of lifestyle interventions on long-term well-being and sleep quality is
scarce. Such research is highly relevant as mental well-being and good sleep quality are impor-
tant determinants of adequate daily life functioning, and could possibly increase motivation to
lose weight and lead to better weight maintenance [17, 18].
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We investigated whether the pre-conception LIFEstyle intervention in women with obesity
and infertility led to improved levels of perceived stress, mood symptoms, sleep quality and
QoL five years after randomization.
Methods
We followed women approximately five (range = 3–8) years after participation in a pre-con-
ception lifestyle intervention trial [19], the LIFEstyle study [20, 21]. The LIFEstyle study was a
randomized controlled trial (RCT) carried out in 23 hospitals in the Netherlands between
2009–2012 (Netherlands Trial Registry (NTR 1530)). The study was approved by the medical
ethics committee of the University Medical Center Groningen (UMCG) (METc code: 2008/
284) and conducted following the principles of the Declaration of Helsinki. Women were eligi-
ble for the LIFEstyle study if they had a body mass index (BMI) of� 29 kg/m2, were between
18 and 39 years of age and had infertility. The inclusion criterion for BMI was chosen based on
previous research reporting declined pregnancy chances with a BMI of� 29 kg/m2 [22]. Infer-
tility was defined as: chronic anovulation; or, unsuccessful attempts to conceive for at least 12
months with an ovulatory cycle. In total 577 women with obesity and infertility provided writ-
ten informed consent and were randomized between a six-month lifestyle intervention group,
and a control group. The six-month lifestyle intervention aimed at 5–10% weight loss or a
BMI< 29 [3] through a healthy diet, increased physical activity and behavioral modification.
Behavior change was targeted by means of motivational counselling, which was effective in
reducing weight in previous research [23, 24]. The motivational counselling was directed
toward:
• Awareness of actual lifestyle leading to obesity.
• Counselling healthy lifestyle measures: the effect of healthy lifestyle, including diet and phys-
ical activity, in relation to subfertility and pregnancy chances, pregnancy complications and
perinatal outcomes.
• Formulating individualized goals regarding diet and physical activity embedded in a "patient
contract". During the intervention individual goals were evaluated, feedback was given and
goals were adapted if necessary. The coaches also provided information about weight regain
and relapse, and how to continue after a setback.
Trained coaches guided the lifestyle intervention, which consisted of six outpatient visits
and four telephone consultations during the six-month intervention period. The intervention
group received infertility treatment as indicated after the six-month intervention period, or if
the weight loss goal of the intervention was reached before the six-month period ended. The
control group received no lifestyle or body-weight related intervention, only prompt infertility
treatment. The results of the effect of the lifestyle intervention on fertility and pregnancy out-
comes have been published previously [21]. Rates of vaginal birth of a healthy singleton at 37
weeks of gestation or more, which was the primary outcome of the study, were not higher in
the intervention group compared to the control group [21]. The lifestyle intervention signifi-
cantly reduced weight and led to improved cardiometabolic health and physical QoL in the
short-term [13].
Of the 577 women who were randomized, three women withdrew informed consent and 10
were lost to follow-up during the first 24 months of the study, leaving a total of 564 women
who completed the original study. For 14 of these women, contact information was unknown
at the time of the follow-up study, or they emigrated, leaving 550 available for the present fol-
low-up. Eligible women for whom contact information was known (n = 550) received an
Effects of preconception lifestyle intervention in women with obesity and infertility on well-being
PLOS ONE | https://doi.org/10.1371/journal.pone.0212914 February 25, 2019 3 / 13
information leaflet at home regarding the follow-up. Women were contacted several times by
mail and telephone in order to include them in the follow-up. The five year follow-up con-
sisted of a questionnaire packet with items regarding QoL and symptoms of depression and
anxiety. This questionnaire also included items regarding education level, self-reported weight,
and parity; a detailed description of the questionnaire packet is provided below. The question-
naire was filled out online or a printed copy was mailed. All eligible women were also invited
in a second information leaflet to participate in a separate visit involving physical measure-
ments and an additional questionnaire packet in which perceived stress and sleep quality were
measured with detailed description provided below. The primary focus of the physical mea-
surements was to assess anthropometrics and cardiometabolic health. The median number of
months between the basic questionnaire and additional visit/questionnaire was five months.
Baseline information at the time of randomization was available for age, ethnic background,
education level, BMI, diagnosis of polycystic ovary syndrome (PCOS), whether the woman
had ever conceived and QoL. During the entire original trial, levels of perceived stress, symp-
toms of depression and anxiety and sleep quality were not assessed.
Perceived stress
The Dutch version of the 10-item perceived stress scale (PSS) was used to measure perceived
stress [25]. This questionnaire has been labelled a valid and internally consistent measure of
perceived stress [26, 27]. A total score was calculated as a sum score from the 10 items.
Mood symptoms
For the assessment of symptoms of depression and anxiety, the Dutch version of the hospital
anxiety and depression scale (HADS) was used [28]. This 14-item questionnaire has demon-
strated good sensitivity and specificity [29, 30]. Seven items measure symptoms of depression,
and the other seven items measure symptoms of anxiety. The total score for depression and
anxiety is the sum score of these items.
Sleep quality
The Dutch version of the Pittsburgh sleep quality index (PSQI) was used to measure sleep
quality. This questionnaire consists of 19 items, with seven subscales from which a total score
can be derived, with higher scores indicating worse sleep quality [31]. The subscales are ‘sub-
jective sleep quality’ based on one question assessing sleep quality, ‘sleep duration’, based on
one question assessing sleep duration, ‘sleep disturbances’ based on nine types of sleep distur-
bances, ‘sleep latency’ based on questions assessing the average time it takes to fall asleep, ‘day
dysfunction’, based on two questions regarding daytime functioning, ‘habitual sleep efficiency’,
based on the time spent in bed sleeping, and ‘use of sleeping medication’, based on one ques-
tion assessing the use of sleep medication. The PSQI has shown good validity and internal con-
sistency [31, 32].
Quality of life
We measured QoL with the Dutch version of the short form 36 (SF-36), a validated question-
naire with 36 questions regarding physical and mental QoL [33–35]. Higher scores indicate
better QoL. The subscales ‘physical functioning’, based on the performance of physical activity
without limitations due to health, ‘role limitations due to physical problems’, based on prob-
lems with work or daily activities as a result of physical health, ‘bodily pain’, based on physical
pain or limitations due to pain, ‘general health’, based on the evaluation of personal health and
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‘vitality’, based on energy levels, form the physical component summary (PCS) of the QoL.
The subscales ‘social functioning’, based on the ability to perform normal social activities, ‘role
limitations due to emotional problems’, based on problems with work or daily activities result-
ing from emotional problems, ‘mental health’, based on feeling peaceful, happy and calm, and
‘vitality’, based on energy levels, form the mental component summary (MCS) of the QoL.
Baseline SF-36 data at time of randomization were also available.
Statistical analyses
Comparisons of follow-up characteristics for the intervention and control groups were per-
formed. Potential selection bias was assessed by comparing the baseline characteristics
between participants and non-participants in the follow-up. Both these assessments were per-
formed with t-tests, Fisher-Freeman-Halton tests and chi-square tests, after the characteristics
and outcome scores were checked for normality. The comparisons between the intervention
and control groups for levels of perceived stress, symptoms of depression and anxiety and
sleep quality were analyzed with t-tests. Changes in the subscales and component scores of
QoL were calculated and used as the outcome in multivariable regression models comparing
the intervention and control groups, covarying for the baseline measurement of that outcome.
Results were considered statistically significant if a p value was < 0.05. Statistical analyses were
performed using IBM SPSS version 24.0 (Armonk, NY, USA).
Results
Participant flow and characteristics
Fig 1 shows the flow of the 550 women invited to take part in the follow-up study. Of the 216
women who provided informed consent to fill out the first questionnaire packet, 38 women
failed to do so in the end. A total of 178 (32%) women participated in the follow-up, of whom
84 women had been allocated to the intervention group and 94 women to the control group.
They filled out the questionnaires regarding depression, anxiety and QoL. Of the 120 women
who provided informed consent to fill out the additional questionnaire, 5 women did not actu-
ally do this. The additional questionnaire measuring perceived stress and sleep quality was
filled out by 115 women (21%), of whom 52 had been in the intervention group and 63 in the
control group. In Table 1 the differences at baseline between the participants and non-partici-
pants in the follow-up are shown.
Non-participants in the follow-up were less often of Western European descent, had PCOS
less often, and had lower scores on the QoL subscales ‘social functioning’, ‘role limitations due
to emotional problems’ and ‘mental health’, indicating worse mental QoL. The mental compo-
nent summary was also significantly lower at baseline for non-participants in the follow-up.
The subscales ‘social functioning’ and ‘mental health’ were significantly better at baseline in
the intervention group of participants, and the subscale ‘role limitations due to emotional
problems’ and the mental component summary were significantly better at baseline in both
the intervention and control groups of participants compared to non-participants in the fol-
low-up. Furthermore, the short-term improvement in physical QoL in the intervention group
was predominantly among women who did not participate in the follow-up (p = 0.01 for non-
participants in the follow-up, p = 0.16 for follow-up participants). Baseline characteristics were
similar between participants who filled out the first questionnaire packet (n = 178) and partici-
pants who filled out the additional questionnaire packet (n = 115) (p� 0.05). The participant
characteristics at follow-up were similar between the intervention and control groups, as
shown in Table 2. Self-reported BMI and weight loss based on self-reported weight at follow-
up were similar for the intervention and control groups.
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Fig 1. Flowchart of participants.
https://doi.org/10.1371/journal.pone.0212914.g001
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Perceived stress, mood symptoms, sleep quality and quality of life
Tables 3 and 4 show the results of the lifestyle intervention on levels of perceived stress, mood
symptoms, and sleep quality. No differences were observed between the intervention and con-
trol group for levels of perceived stress, symptoms of depression and anxiety, or sleep quality.
Table 1. Comparison of baseline characteristics of participants and non-participants in the follow-up of the LIFEstyle study.
Participants (n = 178) Non-participants in the follow-up (n = 396) p value
Age in years (mean, SD) 30.0 (4.2) 29.7 (4.7) 0.41
Western European ethnicity (n, %) 169 (94.9) 333 (84.1) < 0.01
Education level (n, %) 0.07
- Primary school 5 (2.9) 22 (5.9)
- Secondary education 33 (19.0) 98 (26.1)
- Intermediate vocational education 96 (55.5) 170 (45.2)
- Higher vocational education and university 39 (22.5) 86 (22.9)
Body mass index in kg/m2 (mean, SD) 36.0 (3.2) 36.1 (3.5) 0.62
Polycystic ovary syndrome (n, %) 74 (41.6) 127 (32.2) 0.03
Never conceived at baseline (n, %) 114 (64.0) 255 (64.6) 0.91
Baseline quality of life (QoL) measures
Physical functioning (mean, SD) 84.3 (15.5) 83.8 (17.4) 0.76
Role limitations due to physical problems (mean, SD) 80.9 (36.6) 83.7 (32.6) 0.40
Bodily pain (mean, SD) 82.4 (22.8) 81.8 (23.7) 0.82
General health (mean, SD) 66.3 (17.5) 63.4 (18.4) 0.10
Vitality (mean, SD) 61.0 (16.0) 58.1 (17.4) 0.08
Social functioning (mean, SD) 86.4 (15.9) 81.3 (21.6) < 0.01
Role limitations due to emotional problems (mean, SD) 90.0 (25.4) 80.7 (34.9) < 0.01
Mental health (mean, SD) 77.5 (12.2) 72.6 (16.0) < 0.01
Physical Component Summary (PCS) (mean, SD) 49.3 (9.0) 50.2 (9.3) 0.36
Mental Component Summary (MCS) (mean, SD) 52.1 (7.4) 48.5 (10.5) < 0.01
Abbreviations: SD = standard deviation.
https://doi.org/10.1371/journal.pone.0212914.t001
Table 2. Participant characteristics at follow-up.
Lifestyle intervention group (n = 84) Control group (n = 94) p value
Age in years (mean, SD) 35.1 (4.2) 34.8 (4.5) 0.64
Western European ethnicity� (n, %) 78 (92.9) 91 (96.8) 0.23
Education level (n, %) 0.09
- No education 1 (1.2) 0 (0)
- Primary school 0 (0) 4 (4.3)
- Secondary education 21 (25.0) 14 (14.9)
- Intermediate vocational education 41 (48.8) 53 (56.4)
- Higher vocational education and university 21 (25.0) 23 (24.5)
Self-reported body mass index in kg/m2 (mean, SD) 34.4 (5.1) 34.5 (5.0) 0.83
Weight loss in kg based on self-reported weight (mean, SD) -5.2 (13.0) -3.8 (14.3) 0.49
Polycystic ovary syndrome �, diagnosed by Rotterdam 2003 criteria (n, %) 32 (38.1) 42 (44.7) 0.37
No child at follow-up (n, %) 18 (21.4) 15 (16.0) 0.35
� Measured at baseline.
Abbreviations: SD = standard deviation.
https://doi.org/10.1371/journal.pone.0212914.t002
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The effect sizes for these outcomes were all small (Cohen’s d: 0.005 to 0.11). In Table 5, the
results for QoL also showed no difference in change from baseline to follow-up between the
intervention and control groups, and effect sizes again were small (Cohen’s d: 0.036 and
0.176). No differences were observed for any of the outcomes when participants were divided
between women with a child, and women who never conceived (S1, S2 and S3 Tables).
Table 3. Symptoms of depression and anxiety measured by the HADS and perceived stress measured by the PSS five years after lifestyle intervention according to
allocation status.
Intervention group n Control group n Mean difference (95% confidence interval) p value
Symptoms of depression 7.7 (0.4) 84 7.7 (0.3) 94 0.02 (-1.0 to 1.0) 0.97
Symptoms of anxiety 8.0 (0.4) 84 8.2 (0.3) 94 -0.2 (-1.3 to 0.8) 0.68
Perceived stress levels 14.4 (0.9) 52 13.7 (0.6) 63 0.7 (-1.5 to 2.8) 0.54
Data are given as means (Standard Error); the mean difference between intervention and control groups was assessed with student t-tests. Scores can range from 0 to 21
for symptoms of depression and anxiety, and from 0 to 40 for perceived stress levels with higher scores indicating more symptoms.
https://doi.org/10.1371/journal.pone.0212914.t003
Table 4. Sleep quality measured by the PSQI, five years after lifestyle intervention according to allocation status.
Intervention group (n = 52) Control group (n = 63) Mean difference (95% confidence interval) p value
Sleep quality total score 5.4 (0.5) 5.3 (0.4) 0.1 (-1.2 to 1.4) 0.86
- Subjective sleep quality 1.0 (0.1) 1.1 (0.1) -0.01 (-0.3 to 0.3) 0.94
- Sleep duration 0.4 (0.1) 0.5 (0.1) -0.06 (-0.4 to 0.2) 0.71
- Sleep disturbances 1.2 (0.1) 1.2 (0.1) -0.01 (-0.2 to 0.2) 0.96
- Sleep latency 1.1 (0.1) 1.1 (0.1) 0.03 (-0.4 to 0.4) 0.88
- Day dysfunction 0.8 (0.1) 0.7 (0.1) 0.02 (-0.2 to 0.3) 0.88
- Habitual sleep efficiency 0.8 (0.1) 0.8 (0.1) -0.03 (-0.4 to 0.4) 0.87
- Use of sleeping medication 0.1 (0.1) 0.2 (0.1) -0.04 (-0.3 to 0.2) 0.71
Data are given as means (Standard Error); the mean difference between intervention and control groups was assessed with student t-tests. The total score ranges from 0
to 21 where higher scores represent worse sleep quality.
https://doi.org/10.1371/journal.pone.0212914.t004
Table 5. Quality of life measured by the SF-36, change from baseline scores five years after lifestyle intervention according to allocation status.
Intervention group (n = 65) Control group (n = 84) Mean difference (95% confidence interval) p value
Physical functioning 0.7 (2.0) -1.0 (1.8) 1.7 (-3.7 to 7.1) 0.54
Role limitations due to physical problems -1.8 (4.1) -8.4 (3.7) 6.6 (-4.5 to 17.6) 0.24
Bodily pain -6.0 (3.0) -10.1 (2.7) 4.1 (-3.9 to 12.1) 0.31
General health -17.6 (0.4) -17.8 (0.4) -0.2 (-0.9 to 1.4) 0.71
Vitality -1.8 (2.3) -7.3 (2.1) -5.4 (-0.7 to 11.5) 0.08
Social functioning -3.3 (2.4) -4.3 (2.2) 1.0 (-5.4 to 7.4) 0.76
Role limitations due to emotional problems -6.4 (3.9) -6.7 (3.5) 0.3 (-10.1 to 10.7) 0.95
Mental health -3.0 (1.7) -2.4 (1.5) -0.6 (-5.1 to 4.0) 0.81
Physical Component Summary (PCS) -2.5 (1.0) -3.9 (0.9) 1.5 (-1.3 to 4.2) 0.29
Mental Component Summary (MCS) -1.6 (1.1) -1.9 (1.0) 0.3 (-2.6 to 3.2) 0.83
Data are given as mean change scores (Standard Error), adjusted for baseline measurement; the mean difference between intervention and control group was assessed in
multivariable regression models. The scores range from 0 to 100, with higher scores indicating better QoL.
https://doi.org/10.1371/journal.pone.0212914.t005
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Discussion
In this five year follow-up visit of a pre-conception lifestyle RCT in women with obesity
and infertility, we were unable to detect any effects on levels of perceived stress, symptoms
of depression and anxiety, sleep quality and QoL among those who participated in the
follow up.
There are several potential explanations for the null findings in our study. First, a pre-con-
ception lifestyle intervention might not lead to improved levels of perceived stress, mood
symptoms, sleep quality and QoL. On the other hand, effects of the lifestyle intervention on
well-being and sleep quality might only be present if weight loss is maintained over time. Fur-
thermore, this study was not powered for studying effects on mental health five years after
randomization. The effects sizes we observed were very small to small, indicating that even
with sufficient power the effect sizes would be small. Relatively small differences cannot be
detected with the current sample size (post-hoc power QoL: 33%). Lastly, the intervention
might have been more successful in improving mental well-being, if specific factors had
been incorporated in the intervention, including mindfulness or cognitive behavioral ther-
apy [36, 37], or if group sessions had been combined with the individual coaching sessions
[38].
Only 32% of the women who were invited to participate, filled out the first questionnaire
packet, and an even smaller group filled out the additional questionnaire (21%). Women who
participated in the follow-up more often had PCOS, which limits the generalizability of our
results, and may have led to an underestimation of the effect of the intervention on mental
well-being, since PCOS is linked to impaired mental well-being [39]. Women in the control
group were more likely to participate in the follow-up, possibly because they did not partici-
pate in the intervention and thus did not experience the follow-up as a checkup of intervention
effectiveness, and current lifestyle and body composition examination. Mental QoL at baseline
was lower among women who did not participate in the follow-up, indicating that women
with lower mental well-being were less interested in participation or less able to participate in
follow-up measurements, possibly because they were less motivated. This baseline difference
in mental QoL was more pronounced in the intervention group, which might have led to an
underestimation of the long-term effect of the lifestyle intervention on mental QoL. Moreover,
the short-term positive effect of the lifestyle intervention on physical QoL was observed pre-
dominantly among women who did not participate in the follow-up, and not among women
who did participate in the follow-up. This indicates that a specific subgroup of women partici-
pated in the follow-up, mainly those women who did not benefit from the intervention in
terms of improved physical QoL during the LIFEstyle intervention.
Our null findings are not in line with a previous study examining long-term effects of a life-
style intervention. In the Look AHEAD trial, an intensive lifestyle intervention of individual
and group meetings in individuals with overweight or obesity with type 2 diabetes led to
improved mood in both short- and long- terms [38]. The lifestyle intervention also led to long-
term maintained weight loss [40], which was not the case in the selective group that partici-
pated in our follow-up, and could partially explain our findings. Furthermore, the Look
AHEAD intervention was of longer duration (eight years), compared to the six month LIFE-
style intervention, although other evidence suggests intervention duration is not related to the
magnitude of change in symptoms of depression [14]. Besides weight and mood symptoms,
QoL was also assessed in the Look AHEAD trial, and over time a reduction was observed in
physical and mental QoL, with a smaller reduction in the intervention group, compared to
the control group [38]. QoL also reduced over time in the participants of our study, but this
decline was not significantly different between the intervention and control groups. The
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minimal clinically important difference for QoL measured by the SF-36 has been estimated to
be 2–4 points, while in our results a difference in decline between the intervention and control
groups was approximately 1.5 points for physical QoL and 0.3 point for mental QoL. Hence,
even with sufficient power, the long-term differences in QoL between the intervention and
control groups would not have been clinically relevant. The reduction of QoL over time has
been documented in previous research, also among women in the same age group as our sam-
ple. This reduction has been associated with increasing age, suggesting a relation with an
increased prevalence of disease over time [41, 42].
We compared the mean scores of all outcomes to normative general population values.
Overall, levels of perceived stress, depression, anxiety, sleep quality and QoL were comparable
to normative values [31, 43–46]. This suggests our questionnaire data are valid when compared
to normative values.
A strength of this study is the assessment of QoL at baseline and follow-up, providing
information about changes in QoL over time. Limitations include selective participation
and the lack of baseline and short-term data for perceived stress, mood symptoms and sleep
quality. As a result we do not know if the intervention had any short-term effects on these
outcomes.
Despite promising short-term effects on body weight and QoL, we were unable to detect
effects of a lifestyle intervention on levels of perceived stress, mood symptoms, sleep quality
and Qol in women with obesity and infertility five years after randomization. However, future
research regarding lifestyle intervention should investigate long-term effects on these out-
comes, and whether effects on mental well-being depend on weight loss, since mental well-
being and good sleep quality are determinants of daily functioning and may lead to improved
cardiometabolic health. In future research regarding lifestyle interventions, high attrition rates
should be anticipated in power calculations, consequently increasing the number of initial par-
ticipants. Furthermore, since selective participation leads to difficulties in the evaluation of the
effectiveness and the generalizability of the results, novel strategies are needed to engage study
subjects to participate in follow-up measurements.
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